ARTICLE | Clinical News
Nonoxynol-9 Novasome: Began Phase I trial
February 1, 1999 8:00 AM UTC
Novavax Inc. (NOX), Columbia, Md. Product: Nonoxynol-9 Novasome Business: Drug delivery, Reproductive Therapeutic category: Cytotoxic Target: Cellular membranes Description: Liposomal vaginal spermici...